Monday, April 29, 2013

International Stem Cell Corp. (ISCO) Gives Lifeline Skin Care the Winning Edge

On the Lifeline Skin Care website (www.LifelineSkinCare.com) it says “Someday, stem cells will change the world. Today, stem cells will change your skin.” Lifeline Skin Care, a subsidiary of International Stem Cell Corp., produces stem cell based skin care products, leveraging technology only available through its association with ISCO. Although the application of stem cells and their regeneration properties to skin rejuvenation has been heavily popularized, Lifeline Skin Care’s offerings are unique.

Specifically, Lifeline stem cell creams are the only products in the world that contain human, non-embryonic stem cell extracts. This is possible because of ISCO’s development of parthenogenesis, the ability to generate true pluripotent stem cells without the use of a fertilized human embryo. It’s a one-of-a-kind technology that not only avoids the ethical issues common to stem cell application, but also results in stem cells that can be immune-matched to millions of people, avoiding the use of immuno-suppression drugs. ISCO scientists are focused on using these stem cells to treat severe diseases of the eye, the nervous system, and the liver, where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells.

Lifeline skin care is focused on the application of this technology to skin rejuvenation, combining stem cell biology, nanotechnology, and skin cream formulation technology to produce the highest quality, scientifically tested, and most effective anti-aging products available. The company does not license the brand name, the technology, the stem cell extracts, or proprietary ingredients to any other company. Moreover, revenues from Lifeline Skin Care help fund stem cell research for curing regenerative diseases like diabetes and Parkinson’s Disease.

However, to end users, the real life effectiveness of the product is most important, and is backed up by an independent clinical study showing 63% improved skin tone and brightness, 67% decreased wrinkles appearance, 73% increased skin elasticity, and 93% improved skin hydration.

For additional information, visit www.InternationalStemCell.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: